Methylphenidate extended release (Highland Therapeutics)

盐酸哌甲酯（Highland Therapeutics）

Report date: 2025/11/07 20:01:05

Base Information

Drug NameMethylphenidate extended release (Highland Therapeutics)

Drug Alias NameMethylphenidate delayed release (Highland Therapeutics)Methylphenidate hydrochloride extended release (Highland Therapeutics)BenjornaJORNAY PMHLD-200

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine transporter antagonists

TargetsDopamine transporter

Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesHighland Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIronshore Pharmaceuticals & Development Inc

Active IndicationsN/A

Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A